Loading clinical trials...
Loading clinical trials...
A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Watson Pharmaceuticals
NCT06789406 · Urinary Urge Incontinence (UUI), Urinary Frequency (UF), and more
NCT05362292 · Urinary Incontinence, Urge, Urinary Incontinence, and more
NCT07193407 · Overactive Bladder (OAB)
NCT07195656 · Overactive Bladder (OAB)
NCT07209397 · Overactive Bladder, Overactive Bladder (OAB), and more
Birmingham, Alabama
Homewood, Alabama
Mobile, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions